Emmanouil Saloustros, President of the Board of Directors ΕΟΠΕ – HeSMO and Associate Professor of Oncology at University of Thessaly, shared ΕΟΠΕ – HeSMO’s post on LinkedIn, adding:
“I am delighted to see the official launch of the Cardio-Oncology Partnership (Σύμπραξη), a joint initiative of the ΕΟΠΕ – HeSMO,
the Hellenic Society of Cardiology and the Hellenic Cancer Federation | ELLOK.
For me, this partnership represents something much broader than cardio-oncology. It is a blueprint for the future of healthcare.
Cancer and cardiovascular disease remain the two leading causes of morbidity and mortality across Europe. They also share many common, modifiable risk factors. If we truly want to improve population health, prevention cannot be addressed in isolation. We need integrated strategies that promote healthy lifestyles, reduce shared risk factors, enable early detection and ensure long-term follow-up for cancer survivors.
Cardio-oncology demonstrates how this can be achieved in practice: multidisciplinary teams working together across traditional boundaries, with patients as equal partners in designing care pathways that preserve not only survival, but also long-term health and quality of life.
This vision is closely aligned with the ambitions of Europe’s Beating Cancer Plan, the EU Cancer Mission and Greece’s growing commitment to prevention through initiatives such as the ‘Prolamvano‘ programme.
As Greece prepares to assume the Presidency of the Council of the European Union next year, we have a unique opportunity to showcase integrated, patient-centred models of care that bridge specialties rather than separate them. Cardio-oncology can serve as an example of how prevention, innovation and collaboration can come together to build more resilient and sustainable health systems.
I would like to warmly thank our colleagues from the Hellenic Society of Cardiology, ELLOK, the Hellenic Cancer Mission Hub, and everyone who has contributed to making this partnership a reality.
This is only the beginning. Together, we can shape a future where prevention is embedded throughout the cancer journey and where collaboration – not fragmentation – defines the way we care for our patients.”
Quoting ΕΟΠΕ – HeSMO’s post:
“Announcing the Cardio-Oncology Partnership (Sympraxis) : A Joint Initiative of HeSMO, Hellenic Society of Cardiology and Hellenic Cancer Federation | ELLOK.
We are proud to announce the official launch of the Cardio-Oncology Partnership, a joint initiative of the Hellenic Society of Medical Oncology (HeSMO), the Hellenic Society of Cardiology (HSC) and the Hellenic Cancer Federation | ELLOK, Hellenic Cancer Mission Hub.
Cancer care is no longer defined solely by treating the disease. It is increasingly about preserving long-term health and quality of life. Protecting cardiovascular health throughout the cancer journey has therefore become an essential component of modern oncology.
The Partnership aligns with the objectives of Europe’s Beating Cancer Plan, the EU Cancer Mission and the Safe Hearts initiative, while also supporting Greece’s growing emphasis on prevention and early detection, reflected in national initiatives such as the ‘Prolamvano’ (Prevent) preventive screening programme.
Our shared ambition is to develop integrated cardio-oncology care pathways that place prevention at the centre of care, connecting
- Primary prevention and healthy lifestyles
- Early cardiovascular risk assessment
- Risk stratification before and during cancer treatment
- Multidisciplinary management
- Long-term survivorship and cardiovascular follow-up
An additional objective of the Partnership is to promote interdisciplinary education and knowledge exchange, facilitating the dissemination and implementation of evidence-based cardio-oncology practices across the national healthcare system.
A defining strength of this initiative is the partnership between healthcare professionals and the patient community. By bringing together oncologists, cardiologists and patient advocates, we aim to co-design more integrated, patient-centred models of care that reflect not only scientific evidence but also patients’ needs, experiences and priorities.
True innovation is not only about developing new treatments, it is also about preventing complications, preserving long-term health and designing care pathways together with patients.
Together, we believe that prevention, early detection, innovation and collaboration are the foundations of sustainable cancer care. We look forward to working with all our partners to help shape the future of cardiology and oncology collaboration in Greece.”
Other articles featuring Emmanouil Saloustros and ΕΟΠΕ – HeSMO on OncoDaily.